Table 2.
Baseline characteristics of the population (n = 46).
| Mean ±SD or n (%) | |
|---|---|
| Women | 35 (76%) |
| Age (year) | 87.4 ± 6.6 |
| Activities of daily living (ADL/6) | 4.5 ± 1.2 |
| Mini mental state examination (/30) | 19.8 ± 5.7 |
| Comorbidities | |
| Psychiatric disorders | 19 (41%) |
| Cardiovascular disorders | 16 (35%) |
| Neurological disorders | 11 (24%) |
| Osteoarticular disorders | 11 (24%) |
| Cancer | 7 (15%) |
| Diabetes | 4 (9%) |
| Polypharmacy (number of drugs) | 6.3 ± 2.9 |
| Proportion of participant treated with | |
| Proton pump inhibitors | 10 (22%) |
| Statins | 9 (20%) |
| Loop diuretic | 9 (20%) |
| Thiazide diuretic | 4 (9%) |
| Metformin | 2 (4%) |
| Nutritional status | |
| MNA-SF (/14) | 8.2 ± 2.0 |
| MNA-SF ≤ 7 | 14 (30%) |
| BMI | 21.6 ± 3.1 |
| BMI < 21 | 29 (63%) |
| Weight loss | 6 (13%) |
| ≥5% in 1 month | 5 (11%) |
| ≥10% in 6 months | 1 (2%) |
| Albuminemia (g/L) | 36.8 ± 4.0 |
| Albuminemia < 35 g/L | 15 (33%) |
| Transthryretinemia (mg/L) | 224 ± 61 |
BMI, body mass index; MNA-SF, Mini Nutritional Assessment—Short Form.